RedAce Bio
1 known investors
Find your way into RedAce Bio
Sign up to see every warm intro you have to RedAce Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RedAce Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Red Ace is a biotech company developing cancer therapies using what it calls selection gene drive technology, delivering therapeutic gene circuits into tumor cells via tumor-targeted viral vectors. Its approach reprograms cancer cells with synthetic vulnerabilities to overcome drug resistance and work alongside existing oncology treatments.
Investors · 1
Frequently asked questions
- What does RedAce Bio do?
- Red Ace is a biotech company developing cancer therapies using what it calls selection gene drive technology, delivering therapeutic gene circuits into tumor cells via tumor-targeted viral vectors. Its approach reprograms cancer cells with synthetic vulnerabilities to overcome drug resistance and work alongside existing oncology treatments.
- Who are RedAce Bio's investors?
- RedAce Bio's investors include BoxOne Ventures.
